TOMOCUBE, INC.
Jaephil Do serves as the VP of Technology at Tomocube Inc. since January 2022, focusing on discovering new business opportunities. Prior to this role, Jaephil held the position of Chief Strategy Officer at CytoDx from June 2019 to December 2021, leading efforts to enhance rare cell analysis. Experience includes being a Principal Scientist and Team Leader at i-SENS, Inc. from July 2013 to April 2019, where responsibilities involved developing advanced diagnostic platforms. Jaephil held a Senior Manager role at Samsung Electronics & Samsung Medical Center, facilitating collaboration between medical device research and clinical applications. Earlier positions include Research Staff at Samsung Techwin and Samsung Electronics, as well as post-doctoral roles at Boston University and Siloam Biosciences, focusing on innovations in diagnostic and microfluidic technologies. Academic credentials include a Ph.D. in Electrical and Electronics Engineering from the University of Cincinnati and a BS in Electrical and Electronics Engineering from Seoul National University.
This person is not in any offices
TOMOCUBE, INC.
See your samples like never before with Tomocube’s revolutionary label-free, live cell Holotomography. Established in 2015, Tomocube is dedicated to delivering products that enhance biological and medical research via novel optical solutions that can assist scientists and clinicians in understanding, diagnosing, and treating human diseases. Holotomography (HT) technology provides label-free 4D quantitative imaging for analyzing cells and tissues. The details of live cell dynamics, subcellular organelles, and tissue structures can be seen without preparation including fixation, transfection, or staining. Image data acquisition is supported by AI-driven data analysis software for phenotypic analysis using cellular and sub-cellular segmentation. For more on our products and research, e-mail us on info@tomocube.com or visit us at www.tomocube.com